You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

113 Results
Genetic testing looks for mutations or variants in a person’s DNA. These tests can help: predict a person’s predisposition to disease provide...
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Funding:
Exceptional Access Program
    zanubrutinib - For the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) who have received at least one prior therapy; and for the treatment of adult patients with previously untreated CLL.
Mar 2024
Drug
Other Name(s): Brukinsa®
Apr 2024
Regimen
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Oct 2024
Imprimer Ce guide destiné aux patients vous aidera à comprendre ce qui suit : Qu’est-ce que l’anxiété? Quelles peuvent être les sources d’...
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
Dec 2024
Drug
Other Name(s): Gemzar®
Dec 2023
Cancer screening can find abnormal cell changes before they become cancer or cancer at an early stage, when treatment has a better chance of working...
Drug
Other Name(s): Iressa®
Mar 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastric / Stomach
Intent: Palliative
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Intent: Curative
May 2025

Pages